JOHN R. GEISEL

Corporate Board Profile

Tech Score: 0/100

Yubo International Biotech Ltd

Filing Date	Source Excerpt
2001-08-08	John R. Geisel has served as Chief Executive Officer and a Director of the Company since January 2001. From December 1999 until it's acquisition by Cardiac Science, Inc. in June 2000, Mr. Geisel served as Chief Executive Officer of Cadent Medical Corporation, an early-stage medical device company focused on developing personal, wearable defibrillators for patients who are at risk of sudden cardiac arrest. Summary Compensation Table John R. Geisel, Chief Executive Officer 2001 33,333(b) -- 3,900,000 (b) Mr. Geisel began employment with the Company on January 1, 2001 at an annual salary of $200,000 and the amount reflected in the above table reflects two months' compensation.

Filing Date

Source Excerpt

2001-08-08

John R. Geisel has served as Chief Executive Officer and a Director of the Company since January 2001. From December 1999 until it's acquisition by Cardiac Science, Inc. in June 2000, Mr. Geisel served as Chief Executive Officer of Cadent Medical Corporation, an early-stage medical device company focused on developing personal, wearable defibrillators for patients who are at risk of sudden cardiac arrest. Summary Compensation Table John R. Geisel, Chief Executive Officer 2001 33,333(b) -- 3,900,000 (b) Mr. Geisel began employment with the Company on January 1, 2001 at an annual salary of $200,000 and the amount reflected in the above table reflects two months' compensation.

Data sourced from SEC filings. Last updated: 2026-02-03